BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32516781)

  • 1. Proposed Definitions of Typical Lesions in Hidradenitis Suppurativa.
    Daxhelet M; Suppa M; White J; Benhadou F; Thorlacius LR; Jemec GBE; Del Marmol V; Revuz J
    Dermatology; 2020; 236(5):431-438. PubMed ID: 32516781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary.
    Frew JW; Lowes MA; Goldfarb N; Butt M; Piguet V; O'Brien E; Ingram J; Jemec GBE; Tan J; Zouboulis C; Alavi A; Kirby JS
    JAMA Dermatol; 2021 Apr; 157(4):449-455. PubMed ID: 33688910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
    Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
    Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Procedural Definitions for Hidradenitis Suppurativa Developed by Expert Delphi Consensus.
    Bui H; Bechara FG; George R; Goldberg S; Hamzavi I; Kirby JS; Saylor D; Sayed CJ
    JAMA Dermatol; 2023 Apr; 159(4):441-447. PubMed ID: 36811866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation.
    Zouboulis CC; Del Marmol V; Mrowietz U; Prens EP; Tzellos T; Jemec GB
    Dermatology; 2015; 231(2):184-90. PubMed ID: 26139027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic heterogeneity in hidradenitis suppurativa (acne inversa): classification is an essential step toward personalized therapy.
    Ingram JR; Piguet V
    J Invest Dermatol; 2013 Jun; 133(6):1453-6. PubMed ID: 23673498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Wave Medical Infrared Thermography: A Clinical Biomarker of Inflammation in Hidradenitis Suppurativa/Acne Inversa.
    Zouboulis CC; Nogueira da Costa A; Jemec GBE; Trebing D
    Dermatology; 2019; 235(2):144-149. PubMed ID: 30650424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized Photographic Documentation of Hidradenitis Suppurativa/Acne Inversa.
    Zouboulis CC; Nogueira da Costa A
    Dermatology; 2019; 235(1):51-54. PubMed ID: 30368496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation.
    Kozera EK; Porter M; Paek SY; Mintoff D; McMeniman E; Oon HH; Chandran NS; Glasenhardt K; Ring HC; Frew JW
    Dermatology; 2024; 240(3):494-506. PubMed ID: 37963431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
    Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
    Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019.
    Narla S; Price KN; Sachdeva M; Shah M; Shi V; Hamzavi I; Alavi A; Lowes MA
    J Am Acad Dermatol; 2021 Jan; 84(1):120-129. PubMed ID: 32497690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Broad-Spectrum Impact of Hidradenitis Suppurativa on Quality of Life: A Comparison with Psoriasis.
    Sampogna F; Fania L; Mazzanti C; Caggiati A; Pallotta S; Panebianco A; Mastroeni S; Didona B; Pintori G; Abeni D
    Dermatology; 2019; 235(4):308-314. PubMed ID: 31121589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target molecules for future hidradenitis suppurativa treatment.
    Zouboulis CC; Frew JW; Giamarellos-Bourboulis EJ; Jemec GBE; Del Marmol V; Marzano AV; Nikolakis G; Sayed CJ; Tzellos T; Wolk K; Prens EP
    Exp Dermatol; 2021 Jun; 30 Suppl 1():8-17. PubMed ID: 34085329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the severity of hidradenitis suppurativa].
    Revuz J
    Ann Dermatol Venereol; 2015 Dec; 142(12):729-35. PubMed ID: 26372547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11th European Hidradenitis Suppurativa Foundation (EHSF) e.V. Conference - Innovating the HS future.
    Zouboulis CC
    Exp Dermatol; 2022 Sep; 31 Suppl 1():5-8. PubMed ID: 36059188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.